Informations techniques
Exploitant
LUPIN EUROPE GmbH
Présentation
NAMUSCLA 167 mg, gélule
B/30 (CIP : 34009 301 721 2 4)
B/50 (CIP : 34009 301 721 3 1)
B/100 (CIP : 34009 301 721 4 8)
B/200 (CIP : 34009 550 625 8 5)
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
URSxCxSUKETEAZ4W